Medical News

RSS

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

Caraco Pharmaceutical Laboratories, Ltd. has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).

7 Jul 2010

FDA approves Glassia for treating Alpha 1 deficiency

Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.

7 Jul 2010

Consumer groups: Force insurers to provide more details justifying price increases

Kaiser Health News staff writer Julie Appleby reports on the continuing evolution of the new health overhaul's implementation rules: "Consumer advocates this week pushed for tough rules on how much information insurers must provide to justify premium increases, a step required by the new health overhaul law" (Appleby, 7/6).

7 Jul 2010

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

"The Democratic chairman of the House Veterans Affairs Committee lambasted the Obama administration over its handling of an incident at a St. Louis VA center in which more than 1,800 veterans were told they may have been exposed to HIV. ... The Department of Veterans Affairs last month sent a letter to 1,812 patients informing them that could have been exposed to HIV and other deadly viruses because of dental equipment that was insufficiently sterilized over a period of 13 months."

7 Jul 2010

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

7 Jul 2010

Experts show the continuing global impact of Framingham Heart Study

Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.

7 Jul 2010

US WorldMeds launches Revonto for malignant hyperthermia

US WorldMeds is proud to announce the launch of Revonto™ (dantrolene sodium for injection), the first patented scientific advancement in the treatment of malignant hyperthermia (MH). The time to reconstitute dantrolene sodium for injection has been dramatically reduced to approximately 20 seconds or until the solution is clear. Revonto™ retains the cost-savings of the original dantrolene sodium for injection product while offering a significant improvement in pharmacotherapy.

7 Jul 2010

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.

7 Jul 2010

Emergency Medical Services completes acquisition of staffing and management company, Affilion

Emergency Medical Services Corporation (NYSE: EMS) (EMSC or The Company) today announced that its EmCare segment has completed its acquisition of Affilion®, an emergency physician staffing and management company based in Tempe, Arizona. Founded in 2005, Affilion provides emergency department physician staffing and related management services in hospitals in Arizona, New Mexico and Texas. The transaction was completed on June 30, 2010, and Affilion, Inc. has become a wholly owned subsidiary of EmCare Inc.

7 Jul 2010

Dell hedging on health IT investment; Privacy concerns remain

The Wall Street Journal: Dell is hoping to capitalize on its purchase of health technology firm Perot Systems by providing services to new clients such as the 2,600-doctor Methodist Hospital System in Houston. Dell has contracted to create an electronic medical records system for Methodist, a new foray into IT services for the hardware-focused firm.

7 Jul 2010

Some patients pay more at Madison clinic to subsidize others

At the Our Lady of Hope Clinic in Madison, Wis., some patients — about half — pay a premium for boutique -- or concierge -- services, which pays for care for the other half -- those without insurance at all. "Now one year old, the clinic started off slowly but is gaining momentum and seems to be a viable business model, clinic officials said. The clinic has 110 paying patients, called benefactors, and serves about two dozen uninsured people weekly."

7 Jul 2010

Aspire Capital Fund to purchase Bionovo shares of common stock worth $15.0 million

Bionovo, Inc. (Nasdaq: BNVI) announced today that it has entered into a common stock purchase agreement with Aspire Capital Fund LLC, an Illinois limited liability company, which provides that, subject to certain conditions and limitations, Aspire Capital is committed to purchase up to an aggregate of $15.0 million of Bionovo shares of common stock over a two year term, based on prevailing market prices over a period preceding each sale.

7 Jul 2010

Hologic enters definitive agreement to acquire Sentinelle Medical

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has entered into a definitive agreement to acquire Sentinelle Medical Inc., a leading provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software.

From Hologic, Inc. 7 Jul 2010

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

In lab experiments, the researchers have found that this device, a vector, is able to deliver DNA deeply enough into a cell to allow genetic material to be activated - a critical step in gene therapy. This vector is between 2 - and 10 times more effective than other experimental materials, according to the research.

7 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

Labor pushes in Mass. and Minn.; Nurses struggle with job hunt despite shortage

Massachusetts's largest health care union is going to try to pull workers at Boston's leading medical centers: Massachusetts General, Brigham and Women's, Beth Israel Deaconess and Tufts hospitals, The Boston Globe reports. The union, led by Veronica Turner since last month, forged a deal in 2009 with Caritas Christi Health Care that gave 3,000 employees raises and bonuses.

7 Jul 2010

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

Crux Biomedical®Inc. announced today that it has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. The trial will evaluate the safety and efficacy of Crux's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter which is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). It is the first VCF to be developed that is bidirectional and thus permits insertion or retrieval from either the femoral or jugular veins.

7 Jul 2010

International conference focuses on HPV's impact on women

Scientists, clinicians and public health leaders from around the world are gathered in Montreal this week for the 26th International Papillomavirus Conference where they hope to generate awareness about human papillomavirus, Canwest News Service/Gazette reports (Martin/McCallum, 7/4).

7 Jul 2010

PI3 kinase boosts body heat, helps burn excess calories

New findings by UT Southwestern Medical Center researchers suggest that an enzyme in the brain known as PI3 kinase might control the increased generation of body heat that helps burn off excess calories after eating a high-fat meal.

7 Jul 2010

PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine

PuraMed BioScience, announced today that a clinical study of LipiGesic M has been completed. The study design was a double blind, placebo controlled, multi-site study measuring the effectiveness of LipiGesic™ M for the treatment of acute migraine attacks. The next steps include completion of the manuscript, submission for publication in a peer-reviewed medical journal and actual publication. In an effort to maximize the potential for publication, an embargo has been placed on the disclosure of any of the results of this study.

7 Jul 2010

Medical News

Caraco Pharmaceutical Laboratories commences shipping azelastine ophthalmic solution

FDA approves Glassia for treating Alpha 1 deficiency

Consumer groups: Force insurers to provide more details justifying price increases

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

Shire receives FDA approval of Daytrana for ADHD in adolescents

Experts show the continuing global impact of Framingham Heart Study

US WorldMeds launches Revonto for malignant hyperthermia

Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed

Emergency Medical Services completes acquisition of staffing and management company, Affilion

Dell hedging on health IT investment; Privacy concerns remain

Some patients pay more at Madison clinic to subsidize others

Aspire Capital Fund to purchase Bionovo shares of common stock worth $15.0 million

Hologic enters definitive agreement to acquire Sentinelle Medical

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Labor pushes in Mass. and Minn.; Nurses struggle with job hunt despite shortage

Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter

International conference focuses on HPV's impact on women

PI3 kinase boosts body heat, helps burn excess calories

PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News